foxo4-dri cancer regulates endothelial cell senescence via the P53 signaling pathway Development of a novel senolytic
Pay in 4 interest-free payments of $5.77 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Live Spec
Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine foxo4 dri senolytic peptide regulates endothelial cell senescence via the P53 signaling pathway FOXO4 DRI: Human Trial Status, Cancer foxo4 dri cancer Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cells Development of a novel senolytic FOXO4 DRI 10mg
Store: buntepalette-gmbh.de · Domain: buntepalette-gmbh.de




























